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Short title: PRLR deficiency and beige adipocyte  
 
 
 
 
 
Nonstandard abbreviations used in the manuscript: 
 
PRL, prolactin; PRLR, prolactin receptor; PET, positron emission tomography; BAT, brown 
adipose tissue; WAT, white adipose tissue; PRDM16, PR domain containing 16; 
PGC1peroxisome proliferator-activated receptor  coactivator 1FOXC2, forkhead box 
protein C2; Rb, retinoblastoma; IL-6, interleukin-6; HFD, high fat diet; SC, show diet; FDG, 
fluoro-2-deoxyglucose; ADR3, 3-adrenoceptor; ZFP423, 30-zinc finger transcription 
factor; UCP1, uncoupling protein 1; C/EBPȕ, CCAAT/enhancer-binding protein ; PPARȖ, 
peroxisome proliferator-activated receptor ; SREBP1, sterol regulatory element-binding 
protein 1; PBS, phosphate buffered saline. 
 
 3 
ABSTRACT  Stimulating conversion of white fat to metabolically active 
adipocytes (beige fat) constitutes a promising strategy against weight gain and its 
deleterious associated-disorders. We provide direct evidence that prolactin (PRL), best 
known for its actions on the mammary gland, plays a pivotal role in energy balance 
through the control of adipocyte differentiation and fate. Here we show that lack of 
prolactin receptor (PRLR) causes resistance to high fat diet-induced obesity due to 
enhanced energy expenditure and increased metabolic rate. Mutant mice displayed 
reduced fat mass associated with appearance of massive brown-like adipocyte foci in 
perirenal and subcutaneous but not in gonadal fat depots under high fat diet. Positron 
emission tomography imaging further demonstrated the occurrence of these 
thermogenic brown fat depots in adult mice, providing additional support for 
recruitable brown-like adipocytes (beigeing) in white fat depots. Consistent with the 
activation of brown adipose tissue, PRLR inactivation increases expression of master 
genes controlling brown adipocyte fate (PRDM16) and mitochondrial function (PGC1, 
UCP1). Altered pRb/Foxc2 expression suggests that this PRL-regulated pathway may 
contribute to beige cell commitment. Together, these results provide direct genetic 
evidence that PRLR affects energy balance and metabolic adaptation in rodents via 
effects on brown adipose tissue differentiation and function. 
 
 
Key Word: thermogenesis, prolactin, adipocyte 
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INTRODUCTION 
Body weight is finely regulated through energy expenditure, nutritional, neuronal and 
hormonal signals. Organs such as brain, pancreas, liver, skeletal muscle and adipose tissue 
can integrate these endogenous or environmental factors to ensure metabolic homeostasis. 
Prolactin (PRL), initially identified for its ability to stimulate mammary gland development 
and lactation was thereafter suspected to exert pleiotropic functions, including effects on 
growth, development, immunoregulation, brain and behavior, electrolyte and energy 
homeostasis (1-3). However, the physiological relevance of most of these functions in humans 
remains an open issue. 
The biological actions of PRL are mediated by its interaction with PRL receptor (PRLR), 
a member of the cytokine receptor superfamily (4,5). Compared to growth hormone and its 
cognate receptor, the actions of PRL and PRLR on metabolic homeostasis under non-lactating 
conditions have received less attention. However, within the last decade, a wealth of 
experimental data has documented the potential role of PRLR signaling in body weight 
regulation, pancreas development and insulin secretion, and adipose tissue physiology (3). 
Regarding body weight regulation, some conflicting results have emerged from PRLR-/- mice 
while decreased weight gain was observed in 8-9 mo-old PRLR-/- females (6). This was not 
confirmed by subsequent studies in younger animals (7,8). 
Interestingly, several reports described higher body weight in humans with prolactinoma, 
but the mechanisms underlying this association are poorly understood and likely pleiotropic 
(9). Some authors suggest that weight loss in humans occurs after complete or near 
normalization of serum PRL with dopamine agonists (10). Several lines of evidence support a 
direct role for PRL in adipogenesis. PRL enhances the expression of C/EBPȕ and PPARȖ in 
NIH-3T3, two master genes of adipogenesis (11). Lack of PRLR in mice results in an 
impaired development of both parametrial and subcutaneous adipose tissues associated with a 
 5 
lower number of adipocytes without change in their volume (8). PRL signaling also alters 
lipid metabolism through inhibition of lipoprotein lipase activity in human white adipose 
tissue and inhibits adipokine release including leptin, adiponectin and IL-6 (12). In addition, 
PRL potentiates the insulin effect on leptin release in cultured brown adipocytes (13). Most 
important, PRL signaling is essential for normal perinatal brown adipocyte thermogenesis. 
Newborn mice lacking PRLR have hypotrophic BAT depots that express low levels of 
adipogenic markers reducing mouse viability during cold challenge (14). Moreover, 
immortalized PRLR-/- preadipocytes fail to undergo differentiation into mature brown 
adipocytes, and could be rescued by reintroduction of PRLR (14). Interestingly, PRL is also 
released both by primary preadipocytes and adipose explants and its expression changes 
according to white adipose tissue localization, suggesting a potential autocrine-paracrine loop 
in a depot specific manner (15).  
Although all these experimental data converge to support a physiological role of PRLR in 
the control of energy homeostasis, the pathophysiological involvement of this receptor on 
adipocyte plasticity remains unclear. The aim of the present study was to clarify the potential 
adaptive function of PRL signaling under obesogenic conditions. For this purpose, we 
subjected PRLR-/- mice to a high fat diet (HFD) for 16 weeks and analyzed their metabolic 
phenotypes. Remarkably, PRLR-/- mice were highly resistant to HFD-induced obesity, a 
phenomenon that involves a brown conversion of white fat depots defined as beigeing 
(16,17). Thus, manipulations of the PRL signaling pathway could hopefully be translated into 
adjunct therapy to raise energy expenditure and promote weight loss. 
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MATERIALS AND METHODS 
 
Mice 
 
Eight-wk-old PRLR-/- and wild type male mice, on a pure 129/SvJ background, were kept on 
a 12:12 h light-dark cycle in a temperature-controlled colony room and had ad libitum access 
to tap water and were challenged for 16 weeks with standard chow (SC) (17% fat, 23% 
protein, 60% carbohydrates, Harlan, Gannat, France) or high fat diet (HFD) (60% fat, 20% 
protein, 20% carbohydrates, Research Diets, Denmark) (18). Body weight was measured 
weekly. Mice were sacrificed and tissues were removed, weighed and used for subsequent 
gene expression and histological analyses. All procedures were approved by the Ministère de 
l’Agriculture, France.  
 
Body fat determination 
 
Body weight composition was evaluated by Dual-Energy X Ray Absorptiometry (DEXA) 
using a PIXIMUS apparatus (LUNAR Corporation; Madison, WS, USA). Mice were 
anesthetized by ip injection (100 µl/10 g BW) of a saline mixture containing 0.1 % Xylazin 
(Rompun, Bayer Pharma; Puteaux, France) and 10 mg/ml of Ketamin (Imalgène 1000, 
Merial, Lyon, France). Fat mass and lean masses were calculated according to computerized 
measurements of Piximus apparatus. 
 
Metabolic parameters exploration 
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Mice were analyzed for whole body energy expenditure, and oxygen consumption (VO2), 
food intake (g) and spontaneous activities using calorimetric cages with bedding, and had ad 
libitum access to food and water (Labmaster, TSE Systems GmbH, Bad Homburg, Germany). 
Animals were acclimated in individual cages for 48 h before experiments. Data were recorded 
every 40 min during the entire experiment. The flow was calibrated with O2 and CO2 mixture 
of known concentrations before the experiment. Whole energy expenditure was calculated 
according to the Weir equation. Food and water consumptions were recorded by highly 
sensitive online feeding and drinking sensors. Each cage enabled tracking of mice with 
infrared light thus allowing measurement of total activity. The sensors for gases and detection 
of movement operate efficiently in both light and dark phases, allowing continuous recording. 
Mice were monitored for body weight and composition at entry and exit of the experiment. 
Body mass composition (lean tissue mass, fat mass, free water and total water content) was 
analyzed using an EchoMRI (Whole Body Composition Analyzers, Echo Medical Systems, 
Houston, USA). Data analysis was performed using extracted value of VO2 consumed, 
(expressed in ml/kg/h), and energy expenditure (kcal/kg/h).  
 
Plasma measurements 
 
Blood was collected at sacrifice and plasma insulin from 16 h-fasting mice was measured 
using the Ultra Sensitive Insulin ELISA kit (Crystal Chem Inc, Downer Grove, USA). 
Glycemia was determined with Accu-Chek Performa Glucometer (Roche, Bâle, Swisserland). 
Plasma leptin and resistin were measured using the MADPK-71K kit (Millipore, Molsheim, 
France). Total cholesterol levels were determined by enzymatic colorimetric assays (Sobodia, 
Montbonnot-Saint-Martin, France). 
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Homeostasic model assessment (HOMA) determination 
 
HOMA-IR and HOMA-ȕ index were used to quantify insulin resistance and beta cell 
function, respectively. These indexes were determined as follows: HOMA-IR = (glucose x 
insulin)/405 and HOMA-ȕ = (γ60 x insulin)/(glucose – 63) %. Fasting glucose and insulin are 
expressed as mg/dL and mU/L, respectively. 
 
Immunocytochemical and histomorphological procedures 
 
Tissues were fixed overnight in 4% paraformaldehyde, dehydrated, embedded in paraffin, and 
5-µm-thick sections were prepared. Sections were permeabilized with 0.1% Triton X-100 
diluted in PBS for 10 min at room temperature. Sections were rinsed again in PBS, incubated 
in peroxidase blocking solution (3% H2O2 in PBS) for 10 min to block endogenous 
peroxidase activity, rinsed in PBS, and incubated with 5% rabbit serum blocking solution 
diluted with antibody diluent (Cell Marque, Rocklin, USA) for 1 h at room temperature. 
Sections were subsequently incubated overnight at 4°C with goat anti-UCP1 antibody (#sc-
6528, Santa Cruz Biotechnology, Heidelberg, Germany) diluted 1:100. After washes in PBS, 
sections were incubated with biotinylated rabbit anti-goat IgG (Jackson ImmunoResearch 
Laboratories, Inc., Newmarket, UK; diluted 1:500 in blocking solution) for 1 h at room 
temperature. Following three rinses in PBS, sections were incubated with HRP-Streptavidin 
(Vector Laboratories, Peterborough, UK) diluted in PBS for 45 min at room temperature, 
rinsed in PBS, incubated in DAB peroxidase substrate solution for 2–5 min, rinsed in distilled 
water, and coverslipped with glycergel (Dako, Trappes, France). Paraffin-embedded adipose 
sections were analyzed after hematoxylin and eosin staining. Histological quantification was 
performed using the ImageJ software (http://rsbweb.nih.gov/ij/). Adipocyte size was 
 9 
measured on more than 150 cells per depot and per mouse (5 mice for each group). 
Percentage of brown adipose tissue (BAT) was determined by calculating BAT area on total 
area of perirenal adipose tissue.  
 
Western blot analyses 
Total protein extracts were prepared from perirenal WAT isolated from mice. Briefly, WAT 
was lysed as described previously (13) using the Tissuelyser apparatus (Qiagen Courtaboeuf, 
France) then 30 µg of protein were directly submitted to SDS-PAGE. After protein blotting 
on an Odyssey® nitrocellulose membrane, blots were incubated for 1 h at RT in a blocking 
buffer (LI-COR, Lincoln, NE, USA) before an overnight incubation at 4°C with a sheep anti-
UCP1 antibody (1:3,000, kindly provided by Pr. D. Ricquier). After washes, blots were 
incubated with an IRDye 680-conjugated affinity purified anti-sheep IgG second antibody 
(1:10,000, ABM, Richmond, Canada) for 1 h at RT. After washes, proteins were visualized 
with an Odyssey Fc apparatus (LI-COR). GAPDH protein was used as an internal control: 
blots were incubated for 1 h at room temperature with rabbit anti-GAPDH (1:5,000) (Sigma, 
Saint-Quentin Fallavier, France) followed by 1 h incubation at RT with an IRDye 800-
conjugated affinity purified anti-rabbit secondary antibody (1:10,000, Thermo Scientific, 
Illkirch, France). UCP1 infrared fluorescence was normalized to GAPDH as determined by 
densitometry using the Image Studio software (LI-COR). 
 
Positron emission tomography 
 
Positron emission tomography (PET) recording was carried out on 6-mo-old male mice with 
2-[18F]fluoro-2-deoxyglucose (18F-FDG), a 18F-labeled glucose analogue which is known to 
be actively trapped by activated BAT in mice (19,20). After 45 min of cold exposure at 6 °C, 
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each of the 4 analyzed mice received around 15 MBq of 18F-FDG via tail vein injection, and 
45 min later, a whole-body recording was started under continuous anesthesia by isoflurane, 
(5% induction, 1–2% maintenance) and using a dedicated small-animal PET system (Inveon, 
Siemens, Knoxville, Tennessee, USA). After a 30-min recording period and conventional 3D 
image-reconstruction, the volume of the foci with high FDG activity were determined using a 
threshold value of 2 standardized uptake value (SUV): 1) within the interscapular area, which 
is known to be a depot of BAT in normal mice (19,20), and 2) along the remaining part of the 
dorsal walls from the thorax and abdomen and thus, in sites known to normally involve WAT 
in normal conditions. 
 
Gene expression analyses 
 
Quantitative real-time PCR was performed as described previously (14). After DNAse I 
treatment, RNA was reverse-transcribed and used for quantitative RT-PCR (qRT-PCR) using 
the Power SYBR® Green PCR Master Mix (Applied Biosystems). Final primer concentrations 
were 300 nM (see Table 1 for primer sequences). Reaction parameters were carried out on a 
StepOne™ Real-Time PCR System (Applied Biosystems). Relative expression within a given 
sample was calculated as a ratio (amol of specific gene/fmol of 18S). Results are means ± 
SEM. 
 
Data analysis 
 
Data are expressed as means ± SEM. Data were analyzed using a non parametric Mann 
Whitney test or for multiple comparisons, Kruskal-Wallis test followed by Dunn’s post-test as 
appropriate with use of the computer software Prism 5 (GraphPad Software, San Diego, 
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USA). Comparisons between time points were analyzed using linear regression. Statistical 
significance is indicate d at p values <0.05, 0.01 and 0.001.  
 
RESULTS 
 
PRLR-/- mice are resistant to high fat diet-induced obesity despite high food intake 
 
Previous studies on PRLR-/- mice showed a mild body weight difference compared to wild 
type mice (6). We examined whether this receptor inactivation affects body weight regulation. 
We found that PRLR knock-out resulted in a small decrease in the body weight gain over the 
24 weeks when male mice were maintained on standard chow (SC) (Fig. 1A). To further 
investigate the metabolic impact of PRL signaling, we subjected the PRLR-/- and control mice 
to a high fat diet (HFD). As expected, 16 weeks of ad libitum HFD feeding caused a sharp 
increase in body weight in both groups; however, PRLR-/- mice gained 16% less weight than 
controls during the same period (Fig. 1A, p< 0.001). This difference of body weight was 
associated with a profound reduction of adipose mass with no difference in the lean mass as 
revealed by DEXA method (Fig. 1B, 1C p< 0.01). Indeed, examination of body fat mass 
revealed a marked 40% reduction of the perirenal adipose pad normalized to body weight in 
PRLR-/- mice (Fig. 1D, p<0.01) while gonadal and subcutaneous WAT depots, kidney and 
spleen weights (Figs. 1 E-H) were similar, pointing to a genotypic and diet-related difference 
in site-specific adipose depots.  
To investigate the mechanisms underlying the resistance to HFD-induced obesity of 
PRLR-/- mice, we measured behavioral and metabolic adjustments to the diet, given that 
energy intake should equal energy expenditure to maintain energy homeostasis. As depicted 
in Fig. 2A, over 4 consecutive days in metabolism cages, cumulative food intake on SC was 
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significantly increased in PRLR-/- mice compared to controls, the same trend was observed 
when animals were HFD fed. No change in locomotor activity was detected between the 
groups (Supplementary Fig. 1). Oxygen consumption and energy expenditure were 
significantly increased in PRLR-/- mice as compared to WT mice both under SC and after 16 
weeks of HFD feeding regimen (Figs. 2B and 2C). Under HFD, diet-induced enhancement of 
metabolic rate and energy expenditure, normalized to lean mass, were calculated at 9.5% and 
9.8% in control mice, but increased up to 12.8% and 11.9% in PRLR-/- mice, respectively. 
Taken together, our data demonstrate that PRL signaling is involved in normal energy 
expenditure and body weight regulation. 
 
PRLR-/- mice are protected against HFD-induced insulin resistance 
 
To further assess the impact of PRLR deletion on glucose metabolism, we showed that under 
HFD, WT mice exhibited a glucose intolerance associated with a drastic increase in plasma 
insulin levels while PRLR-/- mice improved their glucose homeostasis as revealed by normal 
glycemia with appropriate insulin secretion (Figs. 3A and 3B). Calculated HOMA-IR and 
HOMA- indexes provided additional support for the improvement of insulin resistance and 
the conservation of insulin secretion in the absence of PRLR under HFD (Figs. 3C and 3D). 
Leptin levels were elevated after HFD feeding in both groups, but they were significantly 
lower in the PRLR-/- mice than in control mice as expected from lesser weight gain (Fig. 3E). 
Finally, in contrast to WT mice, resistin levels were unchanged in PRLR-/- mice, whatever the 
diet, excluding a major contribution of this insulin action inhibitor in the prevention of HFD-
induced glucose intolerance (Fig. 3F).  
 
BAT-like remodeling of perirenal wat in PRLR-/- mice 
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We next explored whether the resistance to HFD-induced body weight gain in PRLR-/- mice 
was associated with histomorphological modifications of fat depots. Both subcutaneous and 
gonadal WAT disclosed a marked reduction of adipocyte size in PRLR-/- mice under HFD, 
consistent with the global decrease in fat mass (Supplementary Fig. 2). This suggests a major 
impact of PRL signaling on the adipocyte metabolic activity. Several multilocular brown-like 
adipocytes were detected in perirenal WAT of PRLR-/- HFD-fed males (Fig. 4A). In contrast, 
significantly fewer brown-like adipocytes were found embedded in the perirenal fat depot of 
PRLR+/+ HFD-fed mice (Fig. 4A). Quantification of brown-like adipose area in the perirenal 
tissues showed a dramatic increase of the emergence of browning (Fig. 4B), suggesting that in 
the absence of PRL signaling, HFD induces BAT-like remodeling of perirenal WAT as 
revealed by BAT-specific uncoupling protein 1 (UCP1) immunostaining (Fig. 4C). These 
observations were confirmed by western blot analysis (Fig. 4D) that revealed a three-fold 
increase of UCP1 protein in perirenal WAT of PRLR-/- mice. Further evidence for increased 
metabolic activity in PRLR-/- mice was provided by imaging using positron emission 
tomography (PET scan) of 2-[18F]fluoro-2-deoxyglucose uptake (FDG), a glucose analogue 
taken up avidly by activated BAT in humans as well as in rodents after a cold challenge 
(19,20). As illustrated in Fig. 4E, all mice had large foci of high FDG uptake in the upper part 
of the dorsal body area as visualized on coronal and sagittal sections. PRLR-/- animals 
exhibited additional foci of high FDG activity in the sites known to mainly harbor WAT 
under normal conditions with a calculated FDG activity volume in PRLR-/- animals (785±1.35 
mm3) compared to PRLR+/+ mice (463±1.81 mm3). 
 Among multiple metabolic adaptations, HFD enhances dissipation of chemical energy 
in the form of heat in brown adipocytes (21). This physiological adjustment is achieved 
through activation of PGC1-dependent pathways that leads to mitochondrial biogenesis and 
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increased expression of BAT-selective genes (PRDM16, UCP1). To gather insights into 
adipocyte function and to further evaluate the impact of PRLR on adipocyte differentiation, 
we assessed the expression of brown and adipogenic markers in different WAT depots. As 
presented in Fig. 5A, HFD strongly induced PRDM16, PGC1 UCP1, and adrenoceptor 3 
(AdR3) mRNA expression in perirenal WAT of PRLR-/- mice along with the pronounced 
BAT-like phenotype, contrasting to what was observed under SC. Interestingly, the 
expression of adipogenic markers such as ZFP423, C/EBP PPAR2, and SREBP1 was 
significantly reduced in WAT depots of PRLR-/- mice as compared to those of WT animals 
under SC. This impaired expression of adipogenic genes in WAT was rescued after HFD, 
(Fig. 5B), suggesting that compensatory mechanisms may counteract PRL signaling defects. 
Interestingly, this adaptive brown like-cell programming is highly dependent on the location 
of adipose depots, in subcutaneous but not gonadal fat (Supplementary Fig. 3) in accordance 
with the well-known plasticity of specific fat depot (22,23). Altogether, these data indicate 
that the lack of PRL signaling selectively facilitates BAT-like remodeling under specific 
metabolic conditions. 
 
Altered pRb/Foxc2 pathway is a key molecular switch for beige cell emergence 
 
We next investigated the molecular mechanisms by which the absence of PRL signaling is 
associated with the emergence of UCP1-expressing beige fat cells and resistance to HFD-
induced obesity. We focused our attention on the retinoblastoma protein (pRb), a transcription 
factor involved in cell cycle, previously reported as a downstream effector of PRL signaling 
(24). In addition, given that pRb plays a key role in fate choice of differentiating common 
mesenchymal precursors toward adipocytes (25), we hypothesized that pRb could regulate 
adipocyte differentiation and beige conversion. pRb expression was drastically increased 
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upon HFD whatever the genotype (Fig.. 5C upper panel); however, PRLR-/- mice displayed a 
marked reduction of pRb expression in perirenal depots as compared to PRLR+/+ mice. 
We also investigated Foxc2 expression, another important transcriptional factor regulating 
adipocyte metabolism and mitochondrial function (26). Foxc2 expression was significantly 
reduced in PRLR-/- mice under SC as compared to PRLR+/+ mice, concomitant with the 
reduction of adipogenic markers (see Fig. 5C lower panel). In contrast, Foxc2 mRNA levels 
were greatly enhanced under HFD, consistent with the prominent role of this forkhead 
transcription factor as a key metabolic regulator of brown adipocytes. 
Hence, our experiments demonstrate that in mice lacking PRLR, both perirenal and 
subcutaneous WAT have acquired a brown fat-like phenotype under HFD referred to as 
“beigeing”. In addition, the coordinated changes in pRb and Foxc2 pathways may constitute a 
molecular switch for preferential metabolic transdifferentiation in this model.  
 
DISCUSSION 
 
While PRL is known as the pituitary hormone of lactation, accumulating evidence shows that 
it exerts pleiotropic effects including growth and metabolic actions (2,3). Here, we 
demonstrate that PRLR is an important effector modulating adipocyte fate and differentiation 
with impact on energy homeostasis and adaptive thermogenesis. 
 Despite increased food intake in both SC and HFD, PRLR-/- mice remained leaner than 
controls and were protected against HFD-induced obesity with a marked reduction in 
adiposity, notably in perirenal fat mass. Thus, we hypothesized that change in overall energy 
expenditure may be at least in part responsible for this phenotype. This was supported by 
increased O2 consumption and enhanced heat dissipation that were significantly higher in 
PRLR-/- mice as compared to PRLR+/+ mice. The relative resistance to HFD-induced obesity 
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was accompanied by a more favorable carbohydrate homeostatic profile in PRLR-/- mice, 
consistent with the major implication of PRL signaling in energy balance. However, these 
changes in whole body homeostasis were likely not sufficient to account for the robust 
protection against HFD-induced weight gain. Increased energy expenditure through BAT 
activation constitutes a powerful mechanism by which high calorie intake could be dissipated, 
thereby defending against obesity (27). Indeed, enhanced conversion of white to 
thermogenically active adipocytes observed in PRLR-/- mice seems to be the key regulatory 
event involved in protection against HFD-induced obesity, consistent with a role of PRL 
signaling in adipocyte fate determination and/or reprogramming.  
In accordance with PRL-mediated transcriptional control of proadipogenic factors (11), 
PRLR deficiency was associated with a down-regulation of key regulators of adipocyte 
differentiation, whose expressions were restored to similar extent than in WT mice under 
HFD. Beyond this HFD-induced rescue observed in PRLR-/- mice, the most striking finding is 
the emergence of BAT within white adipose depots. The question of where beige cells 
originate remains unresolved. It has been proposed that the adaptive UCP1-expressing brown-
like adipose cells that develop in WAT in response to cold exposure or beta-adrenergic 
stimulation can be derived either from a specialized compartment of committed brown 
precursors, direct differentiation from white preadipocytes, and/or transdifferentiation from 
mature white adipocytes (28). Regardless of how they arise and the origin of mesenchymatous 
precursors (often referred to as Myf5- and Sca1+ progenitors) (29,30), the development of 
beige adipocytes (17) in perirenal fat tissue correlates well with protection against obesity in   
PRLR-/- mice. New advances in identification of cellular lineage specification have 
highlighted several key regulatory factors in specifying brown fat cell fate including 
PRMD16, a master co-regulator critical for the commitment towards brown adipocyte lineage 
(31,32). Loss of PRDM16 from brown fat precursors caused a massive reduction in molecular 
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and morphological features of brown adipocytes (33). Conversely, transgenic overexpression 
of PRDM16 strongly induced the development of brown-like adipocytes in adipose depots 
(22). Remarkably, under HFD, PRMD16 expression is dramatically induced in the perirenal 
fat depots as well as in the subcutaneous white fat, associated with a concomitant increase of 
BAT markers. This is supported by the emergence of UCP1-expressing adipocytes and 
metabolically active beige cells located in the perirenal and paraspinal areas accounting for 
the increased metabolic rate in absence of PRLR. Accordingly, PRLR-/- mice displayed an 
increased of AdR3 expression, suggesting that PRL signaling may affect sympathetic 
nervous system activity and/or nerve fibers infiltration in fat depots. Altogether, these 
findings demonstrate that PRLR inactivation could lead to the emergence of inducible-brown 
adipocytes and its associated thermogenesis. Remarkably, this beige reprogramming is 
genetically determined (markedly in PRLR-/- mice), induced under HFD and more 
pronounced in specific fat depots. By contrast, the presence of an active PRL signaling could 
participate to the white adipocyte phenotype maintenance of these fat depots. One question 
concerns the signaling molecules involved in acquisition of a brown adipose-like phenotype 
in perirenal depots. pRb has been suggested to regulate adipocyte differentiation (34). In 
addition, p107, a member of Rb family, is also implicated in adipose development. P107-/- 
mice are refractory to HFD-induced fat accumulation associated with an increase of PGC1 
expression (34). Consistently, marked decrease of pRb expression was found in mice deficient 
in fsp27, a member of the cide family protein regulating adipose tissue differentiation (35). 
Gonadal and subcutaneous white fat pads of Fsp27-/- mice are reduced in size compared to 
wild type mice, together with the acquisition of BAT-like phenotype (35). Collectively, these 
findings underscore the implication of pRb pathway in adipocyte fate, in accordance with the 
pRb defect observed in PRLR-/- fat depots. It was shown that pRb-deficient mouse embryonic 
fibroblasts exhibited an increased expression of the Forkhead transcription factor Foxc2 that 
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accompanied a white to brown adipocyte transdifferentiation (36). Similarly, overexpression 
of Foxc2 in adipose tissue leads to a lean and insulin-sensitive phenotype accompanied by an 
increased BAT-like function due to an enhanced mitochondrial biogenesis through activation 
of mitochondrial transcription factors (26,37). PRLR-/- mice under HFD displayed a sharp 
increase in Foxc2 expression, in agreement with the involvement of pRb/Foxc2 pathway in 
the “beigeing” conversion. The functional role of PRL signaling seems to be highly dependent 
upon the developmental stage. Indeed, we have demonstrated that PRLR is pivotal for early 
development of BAT to support neonatal thermogenesis (14). In contrast, during adulthood, 
the absence of PRL signaling is associated with beige conversion, most notably as an adaptive 
mechanism to facilitate high fat-induced thermogenesis. Thus, PRL signaling plays important 
but changing roles in energy homeostasis during the lifespan. This is reminiscent of the 
metabolic action of PRL reported in amphibians (38), fish and birds (1) but far extends the 
pleiotropic function of PRL in mammals. From a metabolic point of view, PRL is critical 
during gestation and lactation, favoring anabolic lipid storages indispensable for energy needs 
during these two major physiological periods. Several lines of evidence suggest that in 
humans, PRL signaling could be involved in energy homeostasis including the orexigenic 
property of PRL (39,40), the genetic association between PRL and obesity (41,42) and the 
relationship between hyperprolactinemia and obesity (43,44). Several recent reports 
confirmed the major role of BAT in the control of energy balance. Thermogenic UCP1-
expressing cells are found interspersed in adult human subcutaneous fat yet their presence 
negatively correlates with weight gain and insulin resistance (45-49). It would be relevant to 
examine whether patients with hyperprolactinemia are less prone to develop a functional BAT 
in response to cold exposure or overfeeding using PET. In sum, our work demonstrates that 
mice lacking PRLR are highly resistant to HFD-induced obesity, owing to the emergence of a 
brown adipose-like phenotype in peculiar white fat depots. This is associated with a 
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concomitant increase of PRDM16, PGC1, AdR3 and Foxc2 that constitutes a molecular 
switching mechanism. This in turn converges towards an activation of thermogenic brown 
capacity with the final increase of UCP1 responsible for heat dissipation and resistance to 
high calorie weight gain. We thus propose that PRL signaling represents an additional 
determinant of energy homeostasis during physiological and pathophysiological conditions. 
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Figure 1. Lack of PRLR impaired HFD-induced obesity in male mice. A: Body weights of 
PRLR+/+ (n=5-9) and PRLR-/- mice (n=8-9) during 16-week time course of standard chow 
(SC) or high fat diet (HFD). Linear regression was performed for each curve and regression 
coefficients were compared. B: Representative images of Dual-Energy X ray Absorptiometry 
(DEXA) analyses in PRLR+/+ and PRLR-/- mice under SC or HFD. C: Determination of body 
fat mass percentage following DEXA analyses (n=5-9). D: Perirenal, E: gonadal and F: 
subcutaneaous white adipose tissue (WAT)/Body Weight (BW) ratio were determined on 6-
mo-old PRLR+/+ (n=5-9) and PRLR-/- (n=8-9) mice. Results are expressed as mean ± SEM of 
WAT mass (mg)/BW (g) (‰). G: Kidney and H: spleen mass. Results are expressed as mean 
± SEM of tissue mass (g), (*p<0.05, **p<0.01, ***p<0.001). 
 
Figure 2. Increased energy expenditure in PRLR-/- mice despite hyperphagia. Metabolic 
parameters were determined with metabolic cages on 6-mo-old PRLR+/+ and PRLR-/- males 
under SC or HFD. A: Food intake (SC) is represented as cumulative ingested Kcal every hour 
(left panel) or Kcal/kg/h (right panel) (*p<0.05). B: O2 consumption is expressed as ml/kg for 
each hour or ml/kg/h (circadian profile, left panels). C: Energy expenditure is expressed as 
mean kcal/kg for each hour or as kcal/kg/h (circadian profile, right panels) (*p<0.05). 
 
Figure 3. PRLR-/- mice are protected against HFD-induced diabetes. A: Basal glycemia and 
B: Plasma insulin were measured from 6-mo-old PRLR-/- and PRLR+/+ males fasted for 16 h. 
(n=5-9 per group). C: HOMA-IR and D: HOMA-ȕ indexes were determined from basal 
glycemia and insulinemia as described in Experimental Procedures Section. E: Plasma leptin 
and F: resistin levels were measured in PRLR-/- and PRLR+/+ mice (n=9-10 per group). 
(*p<0.05, **p<0.01, ***p<0.001). 
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Figure 4. Emergence of brown adipocytes in white fat depots in PRLR-/- male mice. A: 
Paraffin-embedded perirenal WAT sections of PRLR+/+ and PRLR-/- mice under SC and HFD 
(n=3-5 per group) were stained with haematoxylin and eosin (H&E). B: Percentage of BAT in 
perirenal WAT was assessed with ImageJ software. C: Representative photomicrographs of 
perirenal WAT sections of UCP1 immunostaining (IHC). D: Western blot analysis of UCP1 
in perirenal WAT of PRLR-/- HFD fed compared to controls. Thirty µg of proteins were 
loaded for immunoblotting with specific antibodies raised against UCP1 and GAPDH. Four 
µg of BAT proteins were used as a positive control (representative illustration of 3 PRLR+/+ 
and 3 PRLR-/- WAT). UCP1 infrared fluorescence normalized to that of the GAPDH was 
determined by densitometry using the Image Studio software (LI-COR) and expressed as fold 
induction (*p<0.05, n = 4-6 per group). E: Coronal and sagittal FDG-PET slices obtained 
after a cold stress (45 min at 6°C) in PRLR+/+ and PRLR-/- HFD fed mice (see Supplemental 
Material). Areas of high FDG uptake (standardized uptake value > 2) are represented in 
orange to white colors.  
 
Figure 5. PRLR controls beige cell transdifferentiation through pRb signaling. A: Expression 
of brown fat markers (PRDM16, PGC1α, UCP1, AdRȕγ) and of adipocyte differentiation 
genes (ZFP4βγ, C/EBPα, PPARȖβ and SREBP1), normalized to 18S mRNA levels, were 
quantified by qPCR in perirenal WAT of 6 mo-old male mice from both genotypes (n=8-10). 
B: pRb and Foxc2 mRNA levels were determined by qPCR in perirenal WAT. FoxC2 
expression was significantly lower in PRLR-/- mice under SC. (*p<0.05, *p<0.01, 
***p<0.001, n=8-10 per group). 
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Table 1.  Primer Sequences of Genes Analyzed in quantitative RT-PCR 
 
The abbreviations of the genes, their GENBANK or NCBI accession number and 5’- to γ’- nucleotide 
sequences of the sense and antisense primers are presented. 
 
 
Name Accession number Amplicon Sense primer Antisense primer 
18S X00686 66 bp CCCTGCCCTTTGTACACACC CGATCCGAGGGCCTCACTA 
PRDM16 NM_027504 78 bp CTTCTCCGAGATCCGAAACTTC GATCTCAGGCCGTTTGTCCAT 
PGC-1 AF049330 162 bp CCCAGGCAGTAGATCCTCTTCAA CCTTTCGTGCTCATAGGCTTCATA 
UCP1 BC01270 150 bp GCCAAAGTCCGCCTTCAGAT TGATTTGCCTCTGAATGCCC 
AdR3 NM_013462 150 bp TGCGCACCTTAGGTCTCATTAT AAGGCGGAGTTGGCATAGC 
ZFP423 NM_033327 95 bp CCCCCTGATGGGAATAATGC GCAATGCGCCTGTTGGA 
C/EBP NM_007678 116 bp CGCAAGAGCCGAGATAAAGC CAGTTCACGGCTCAGCTGTTC 
PPAR2 U09138 161 bp GCATCAGGCTTCCACTATGGA AAGGCACTTCTGAAACCGACA 
SREBP1 NM_011480 83 bp CGGCCCCTTCCCTCTACTC AGATACCACGATTGTTTTGGAAGTG 
pRb1 NM_009029 89 bp CTGGCCTGTGCTCTTGAAGTT CCACGGGAAGGACAAATCTGT 
Foxc2 NM_013519 120 bp TCCATGGGAACCTTCTTCGA GATCTCAAACTGAGCTGCGGATA 
 
 
 
 
Supplemental Fig. S1.  
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Measurement of ambulatory movements is expressed as number of counts for each hour 
(circadian profile, left panel) or as mean counts/hour (right panel). No significant difference 
was observed between genotypes. 
 
Supplemental Fig. S2.  
Adipocytes are smaller in PRLR-/- mice. (A) Representative micrographs of paraffin-
embedded gonadal WAT sections (x 200) from PRLR+/+ and PRLR-/- mice under SC and 
HFD. These sections were stained with haematoxylin and eosin (H&E) and adipocyte size 
was determined from subcutaneous (B) and gonadal (C) WAT by using the ImageJ software. 
Results are mean ± SEM of at least 150 determinations per animal (*p<0.05, **p<0.01, n=5 
per group). 
 
Supplemental Fig. S3. Brown Fat-like cell development is depot-specific in PRLR-/- mice. 
Expression of brown adipocytes (PRDM16 and UCP1) and adipocyte differentiation genes 
(PPARȖβ, ZFP423 and C/EBPα) was measured by qPCR in subcutaneous (A) and gonadal 
(B) WAT of PRLR+/+ and PRLR-/- mice under HFD. Under HFD, brown fat marker 
expression is decreased in gonadal but not in subcutaneous WAT of PRLR-/- mice compared 
with PRLR+/+ animals (*p<0.05, **p<0.01, n=8-10 per group). 
 
 
 
